Publicacións nas que colabora con Francisco Marín Ortuño (18)

2024

  1. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

2023

  1. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  2. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

2022

  1. Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry

    Journal of the American Heart Association, Vol. 11, Núm. 13

  2. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    International Journal of Clinical Practice, Vol. 2022

2021

  1. Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

    Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633

  2. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615

  3. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  4. In-hospital outcomes of mechanical complications in acute myocardial infarction: Analysis from a nationwide spanish database

    Cardiology Journal, Vol. 28, Núm. 4, pp. 589-597

  5. Influencia de las comorbilidades en la decisión del tratamiento invasivo en ancianos con SCASEST

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  6. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  7. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  8. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

    American Heart Journal, Vol. 237, pp. 104-115

  9. Sex differences in the management of patients with acute coronary syndrome: A population-based ecological cross-sectional study in Spain

    REC: CardioClinics, Vol. 56, Núm. 3, pp. 168-178

  10. Underlying heart diseases and acute covid-19 outcomes

    Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214

2020

  1. Beneficio del tratamiento invasivo en ancianos con comorbilidades y síndrome coronario agudo sin elevación del ST

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 315-315

  2. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry

    Journal of Nephrology, Vol. 33, Núm. 4, pp. 737-745

  3. Relevancia de la carga de comorbilidades en el manejo invasivo del síndrome coronario agudo en pacientes ancianos

    REC: Interventional Cardiology, Vol. 2, Núm. 4, pp. 316-316